WITHDRAWN: Risk of hematologic toxicities and peripheral neuropathy with nab-paclitaxel in treatment of malignancy: an up-to-date metaanalysis

Yihua Liu, Hongsheng Lin, Ying Zhang et al.|Oncotarget|2017

Cited by 0